- Home
- CSBR vs CEE Comparison
CSBR vs CEE Comparison
Compare CSBR & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- CEE
- Stock Information
- Founded
- CSBR 1985
- CEE 1990
- Country
- CSBR United States
- CEE Germany
- Employees
- CSBR N/A
- CEE N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- CEE Finance Companies
- Sector
- CSBR Health Care
- CEE Finance
- Exchange
- CSBR Nasdaq
- CEE Nasdaq
- Market Cap
- CSBR 65.9M
- CEE 75.8M
- IPO Year
- CSBR 1986
- CEE N/A
- Fundamental
- Price
- CSBR $4.44
- CEE $12.14
- Analyst Decision
- CSBR Strong Buy
- CEE
- Analyst Count
- CSBR 1
- CEE 0
- Target Price
- CSBR $6.00
- CEE N/A
- AVG Volume (30 Days)
- CSBR 11.4K
- CEE 22.0K
- Earning Date
- CSBR 12-10-2024
- CEE 01-01-0001
- Dividend Yield
- CSBR N/A
- CEE 3.86%
- EPS Growth
- CSBR N/A
- CEE N/A
- EPS
- CSBR N/A
- CEE N/A
- Revenue
- CSBR $51,655,000.00
- CEE N/A
- Revenue This Year
- CSBR $9.27
- CEE N/A
- Revenue Next Year
- CSBR $9.76
- CEE N/A
- P/E Ratio
- CSBR N/A
- CEE N/A
- Revenue Growth
- CSBR N/A
- CEE N/A
- 52 Week Low
- CSBR $3.60
- CEE $7.80
- 52 Week High
- CSBR $7.13
- CEE $10.32
- Technical
- Relative Strength Index (RSI)
- CSBR 51.57
- CEE 61.19
- Support Level
- CSBR $4.26
- CEE $11.50
- Resistance Level
- CSBR $4.70
- CEE $12.31
- Average True Range (ATR)
- CSBR 0.26
- CEE 0.51
- MACD
- CSBR 0.02
- CEE -0.02
- Stochastic Oscillator
- CSBR 64.86
- CEE 55.83
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.